Search Results

There are 7855263 results for: content related to: Nuclear Medicine in Neurodegenerative Disorders

  1. FP-CIT and MIBG scintigraphy in early Parkinson's disease

    Movement Disorders

    Volume 20, Issue 5, May 2005, Pages: 552–561, Jörg Spiegel, Marc-Oliver Möllers, Wolfgang H. Jost, Gerhard Fuss, Samuel Samnick, Ulrich Dillmann, Georg Becker and Carl-Martin Kirsch

    Version of Record online : 11 JAN 2005, DOI: 10.1002/mds.20369

  2. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders

    Movement Disorders

    Volume 24, Issue S2, 2009, Pages: S732–S741, Olivier Rascol and Ludwig Schelosky

    Version of Record online : 28 OCT 2009, DOI: 10.1002/mds.22499

  3. Functional Neuroimaging of Sympathetic Innervation of the Heart

    Annals of the New York Academy of Sciences

    Volume 1018, Issue 1, June 2004, Pages: 231–243, DAVID S. GOLDSTEIN

    Version of Record online : 16 JAN 2006, DOI: 10.1196/annals.1296.028

  4. Diagnostic Performance of Myocardial Innervation Imaging Using MIBG Scintigraphy in Differential Diagnosis between Dementia with Lewy Bodies and Other Dementias: A Systematic Review and a Meta-Analysis

    Journal of Neuroimaging

    Volume 22, Issue 2, April 2012, Pages: 111–117, Giorgio Treglia and Ernesto Cason

    Version of Record online : 17 NOV 2010, DOI: 10.1111/j.1552-6569.2010.00532.x

  5. 123I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial

    Pediatric Blood & Cancer

    Volume 52, Issue 7, 1 July 2009, Pages: 784–790, Terry A. Vik, Thomas Pfluger, Richard Kadota, Victoria Castel, Mark Tulchinsky, J.C. Alonso Farto, Sherif Heiba, Aldo Serafini, Sabah Tumeh, Natalie Khutoryansky and Arnold F. Jacobson

    Version of Record online : 30 JAN 2009, DOI: 10.1002/pbc.21932

  6. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

    Movement Disorders

    Volume 24, Issue 7, 15 May 2009, Pages: 949–964, David J. Brooks, Klaus Seppi and for the Neuroimaging Working Group on MSA

    Version of Record online : 20 MAR 2009, DOI: 10.1002/mds.22413

  7. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors

    Movement Disorders

    Volume 24, Issue 15, 15 November 2009, Pages: 2242–2248, Fabiana Novellino, Gennarina Arabia, Antonio Bagnato, Giuseppe Lucio Cascini, Maria Salsone, Giuseppe Nicoletti, Demetrio Messina, Maurizio Morelli, Sandra Paglionico, Laura Giofrè, Antonino Restuccia, Giusi Torchia, Francesca Condino and Aldo Quattrone

    Version of Record online : 30 SEP 2009, DOI: 10.1002/mds.22771

  8. Role of DAT-SPECT in the diagnostic work up of Parkinsonism

    Movement Disorders

    Volume 22, Issue 9, 15 July 2007, Pages: 1229–1238, Christoph Scherfler, Johannes Schwarz, Angelo Antonini, Donald Grosset, Francesc Valldeoriola, Kenneth Marek, Wolfgang Oertel, Eduardo Tolosa, Andrew J. Lees and Werner Poewe

    Version of Record online : 7 MAY 2007, DOI: 10.1002/mds.21505

  9. Current Trends in Functional Imaging of Pheochromocytomas and Paragangliomas

    Annals of the New York Academy of Sciences

    Volume 1073, Issue 1, August 2006, Pages: 374–382, BARRY L. SHULKIN, IOANNIS ILIAS, JAMES C. SISSON and KAREL PACAK

    Version of Record online : 7 SEP 2006, DOI: 10.1196/annals.1353.041

  10. You have free access to this content
    References

    Pheochromocytoma: Diagnosis, Localization, and Treatment

    Karel Pacak, Jacques W. M. Lenders, Graeme Eisenhofer, Pages: 120–165, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470692196.refs

  11. The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[18F]fluoro-A-85380

    Synapse

    Volume 63, Issue 9, September 2009, Pages: 752–763, J.R. Ellis, P.J. Nathan, V.L. Villemagne, R.S. Mulligan, K.A. Ellis, H.J. Tochon-Danguy, J.G. Chan, G.J. O'keefe, J. Bradley, G. Savage and C.C. Rowe

    Version of Record online : 29 MAY 2009, DOI: 10.1002/syn.20642

  12. Do dopamine agonists or levodopa modify Parkinson's disease progression?

    European Journal of Neurology

    Volume 9, Issue s3, November 2002, Pages: 15–22, K. Marek, D. Jennings and J. Seibyl

    Version of Record online : 11 DEC 2002, DOI: 10.1046/j.1468-1331.9.s3.2.x

  13. Comparison of 123I-metaiodobenzylguanidine (MIBG) and 131I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: A report from the Children's Oncology Group

    Pediatric Blood & Cancer

    Volume 56, Issue 7, 1 July 2011, Pages: 1041–1045, Arlene Naranjo, Marguerite T. Parisi, Barry L. Shulkin, Wendy B. London, Katherine K. Matthay, Susan G. Kreissman and Gregory A. Yanik

    Version of Record online : 15 FEB 2011, DOI: 10.1002/pbc.22991

  14. Cognitive Impairment and the Dementias

    Geriatric Neurology

    Ranjan Duara, Miriam Jocelyn Rodriguez, David A. Loewenstein, Martin R. Farlow, Clive Ballard, Helena C. Chui, Freddi Segal-Gidan, David Perry, Howard Rosen, Maya L. Henry, Stephen M. Wilson, Steven Z. Rapcsak, Michael D. Geschwind, Katherine Wong, Norman R. Relkin, Pages: 181–286, 2014

    Published Online : 28 MAR 2014, DOI: 10.1002/9781118730676.ch9

  15. Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy

    Movement Disorders

    Volume 22, Issue 11, 15 August 2007, Pages: 1594–1600, Naomi M. Warren, Margaret A. Piggott, Elizabeth Greally, Michelle Lake, Andrew J. Lees and David J. Burn

    Version of Record online : 29 MAY 2007, DOI: 10.1002/mds.21573

  16. In Vivo Imaging of Neurotransmission and Brain Receptors in Dementia

    Journal of Neuroimaging

    Volume 18, Issue 2, April 2008, Pages: 111–124, Sabina Pappatà, Elena Salvatore and Alfredo Postiglione

    Version of Record online : 29 MAR 2008, DOI: 10.1111/j.1552-6569.2007.00194.x

  17. USE OF [123I]-2-IODO-l-PHENYLALANINE AS A TUMOR IMAGING AGENT IN TWO DOGS WITH SYNOVIAL CELL SARCOMA

    Veterinary Radiology & Ultrasound

    Volume 48, Issue 5, September–October 2007, Pages: 471–474, K. PEREMANS, V. KERSEMANS, T. LIUTI, E. VANDERMEULEN, B. CORNELISSEN, I. GIELEN, B. DE SPIEGELEER, J. MERTENS, C. BURVENICH and G. SLEGERS

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1740-8261.2007.00281.x

  18. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

    Movement Disorders

    Volume 18, Issue 8, August 2003, Pages: 890–897, Frédéric Courbon, Christine Brefel-Courbon, Claire Thalamas, Marie Jeanne Alibelli, Isabelle Berry, Jean-Louis Montastruc, Olivier Rascol and Jean-Michel Senard

    Version of Record online : 8 APR 2003, DOI: 10.1002/mds.10461

  19. Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

    Movement Disorders

    Volume 19, Issue 10, October 2004, Pages: 1196–1202, Ulrike Sommer, Thomas Hummel, Katja Cormann, Antje Mueller, Johannes Frasnelli, Joachim Kropp and Heinz Reichmann

    Version of Record online : 13 MAY 2004, DOI: 10.1002/mds.20141

  20. Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression

    Annals of Neurology

    Volume 64, Issue S2, December 2008, Pages: S111–S121, Kenneth Marek, Danna Jennings, Gilles Tamagnan and John Seibyl

    Version of Record online : 6 JAN 2009, DOI: 10.1002/ana.21602